Topic: Frank D Amelio

Pfizer CFO Frank D'Amelio informed analysts that the company views the shift from a pandemic to an "endemic" state as a significant commercial opportunity. He noted that once normal market forces return, Pfizer can increase pricing and implement annual booster shots. The discussion highlights the financial incentives for pharmaceutical companies to ensure the virus remains a permanent fixture in society.